Ignite Creation Date:
2024-05-06 @ 5:51 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05451043
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2022-07-05
Brief Title:
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors BLOCKED
Sponsor:
AHS Cancer Control Alberta
Organization:
AHS Cancer Control Alberta
Organization Data
Organization:
AHS Cancer Control Alberta
Class:
OTHER
Study ID:
IIT-0027
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AHS Cancer Control Alberta
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None